ArticleERJ open research2025
Performance of risk prediction scores for severe pneumonia in patients with community-acquired pneumonia after organ transplantation.
Article in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epidemiology, risk factors and clinical outcome of community-acquired pneumonia in severely immunosuppressed patients: a comprehensive analysis from the multinational, prospective CAPNETZ Cohort.ERJ open research · 2026Article
- Pneumonia after Solid Organ Transplantation.Seminars in respiratory and critical care medicine · 2026Review
- Immune monitoring, immune phenotyping, and precision intervention in severe pneumonia: current evidence and translational challenges.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Several predictive scoring systems have been developed to improve the clinical management of patients with community-acquired pneumonia (CAP) and optimise resource allocation. None of the current scores have been validated for immunosuppressed patients and data on outcome of CAP in solid organ transplant recipients are scarce. What is the predictive value of pneumonia severity scores in solid organ transplant recipients with CAP? Study design and methods: We retrospectively analysed 333 first CAP episodes after lung, kidney and liver transplantation between 1 January 2010 and 31 May 2021. We assessed clinical outcomes and evaluated six risk scores (CRB-65 (confusion, respiratory frequency ≥30 breaths·min Results: None of the scores showed adequate prognostic values to guide clinical management of patients in our cohort. The IDSA/ATS 2007 minor criteria, SOFA and NEWS2 performed best in predicting both severe pneumonia and in-hospital mortality, with area-under-the-curve values between 0.72 and 0.67. Conclusion: This comprehensive analysis of CAP in solid organ transplant recipients emphasises the complexity of managing this population and the need for transplant-specific risk assessment tools to improve patient management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.